Exposure to nitrosamine increases the likelihood of developing oesophageal and gastric cancer. Nitrosamine is commonly added to processed meats like bacon, ham, sausages, and hot dogs, making frequent consumption of these foods a risk factor for these types of cancer. Nitrosamine is also present in tobacco smoke. On the other hand, flavonoids, which are abundant in plants, have been linked to a decreased risk of gastric cancer. Acrylamide is present in starchy foods, while fluoride is used in water and toothpaste to prevent tooth decay.

Understanding Carcinogens and Their Link to Cancer

Carcinogens are substances that have the potential to cause cancer. These substances can be found in various forms, including chemicals, radiation, and viruses. Aflatoxin, which is produced by Aspergillus, is a carcinogen that can cause liver cancer. Aniline dyes, on the other hand, can lead to bladder cancer, while asbestos is known to cause mesothelioma and bronchial carcinoma. Nitrosamines are another type of carcinogen that can cause oesophageal and gastric cancer, while vinyl chloride can lead to hepatic angiosarcoma.

It is important to understand the link between carcinogens and cancer, as exposure to these substances can increase the risk of developing the disease. By identifying and avoiding potential carcinogens, individuals can take steps to reduce their risk of cancer. Additionally, researchers continue to study the effects of various substances on the body, in order to better understand the mechanisms behind cancer development and to develop new treatments and prevention strategies. With continued research and education, it is possible to reduce the impact of carcinogens on human health.

Vitamin B12 can be found in animal products, including meat. In order for it to be absorbed in the body’s terminal ileum, intrinsic factor is necessary. This factor is produced by the stomach’s parietal cells. The body stores around 2-3 mg of vitamin B12, which can last for 2-4 years. As a result, signs of B12 deficiency usually do not appear until after a prolonged period of insufficient consumption.

Vitamin B12 is essential for the development of red blood cells and the maintenance of the nervous system. It is absorbed through the binding of intrinsic factor, which is secreted by parietal cells in the stomach, and actively absorbed in the terminal ileum. A deficiency in vitamin B12 can be caused by pernicious anaemia, post gastrectomy, a vegan or poor diet, disorders or surgery of the terminal ileum, Crohn’s disease, or metformin use.

Symptoms of vitamin B12 deficiency include macrocytic anaemia, a sore tongue and mouth, neurological symptoms, and neuropsychiatric symptoms such as mood disturbances. The dorsal column is usually affected first, leading to joint position and vibration issues before distal paraesthesia.

Management of vitamin B12 deficiency involves administering 1 mg of IM hydroxocobalamin three times a week for two weeks, followed by once every three months if there is no neurological involvement. If a patient is also deficient in folic acid, it is important to treat the B12 deficiency first to avoid subacute combined degeneration of the cord.

The superior mesenteric lymph nodes are responsible for draining the duodenum, which is the second section of the gastrointestinal system. This lymphatic drainage is important for staging gastrointestinal cancers, and is similar to the blood supply of the gut. While the coeliac lymph nodes drain the first part of the gastrointestinal system, the inferior mesenteric lymph nodes drain the third part, and the internal iliac lymph nodes drain the lower part of the rectum and some of the anal canal. The para-aortic lymph nodes are not involved in the drainage of the gastrointestinal system, but instead drain the genito-urinary system. It is important to understand the correct lymphatic drainage patterns for accurate cancer staging.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

Common Tumours in Children Under 1 Year Old

Embryonal ‘-blastoma’ tumours are frequently found in children under 1 year old. These tumours include retinoblastoma, neuroblastoma, nephroblastoma, medulloblastoma, and hepatoblastoma. Among these, neuroblastoma is the most common and typically affects infants under 1 year old. It originates from neural crest cells in the adrenal medulla and often presents as a large abdominal mass in an otherwise healthy child.

Acute lymphoblastic leukaemia (ALL) is the most common cancer in children overall, but it is less common in infants under 1 year old. Unfortunately, the prognosis for those who develop ALL before their first birthday is poorer. Astrocytomas, the most common type of CNS tumour, tend to affect slightly older children.

Retinoblastomas are embryonal tumours of the retina, with half being spontaneous and the other half being familial due to an inherited mutation in the pRB tumour suppressor gene. Wilms’ tumour, also known as nephroblastoma, is another embryonal tumour that affects the kidneys and may present as an abdominal mass in infants.

In summary, embryonal ‘-blastoma’ tumours are common in children under 1 year old, with neuroblastoma being the most prevalent. Other tumours, such as ALL and astrocytomas, tend to affect slightly older children. Early detection and treatment are crucial for improving outcomes in these young patients.

Apixaban directly inhibits factor Xa, while bivalirudin and dabigatran directly inhibit thrombin. On the other hand, enoxaparin is a type of low molecular weight heparin that indirectly inhibits factor Xa by forming a complex with antithrombin III, leading to irreversible inactivation of factor Xa.

Direct oral anticoagulants (DOACs) are medications used to prevent stroke in non-valvular atrial fibrillation (AF), as well as for the prevention and treatment of venous thromboembolism (VTE). To be prescribed DOACs for stroke prevention, patients must have certain risk factors, such as a prior stroke or transient ischaemic attack, age 75 or older, hypertension, diabetes mellitus, or heart failure. There are four DOACs available, each with a different mechanism of action and method of excretion. Dabigatran is a direct thrombin inhibitor, while rivaroxaban, apixaban, and edoxaban are direct factor Xa inhibitors. The majority of DOACs are excreted either through the kidneys or the liver, with the exception of apixaban and edoxaban, which are excreted through the feces. Reversal agents are available for dabigatran and rivaroxaban, but not for apixaban or edoxaban.

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.

Methotrexate treatment can lead to megaloblastic macrocytic anemia due to a deficiency of folate.

The patient’s low hemoglobin and high MCV indicate macrocytic anemia, which can be caused by various factors such as alcohol abuse, hypothyroidism, aplastic anemia, and megaloblastic anemia due to a deficiency of vitamin B12 and/or folate. In this case, the patient has a history of rheumatoid arthritis and takes methotrexate weekly, which inhibits dihydrofolate reductase and causes a deficiency of folate. Therefore, folate deficiency is the most probable cause of the patient’s anemia.

Alcohol excess is an incorrect option as it usually requires larger quantities of alcohol to cause macrocytic anemia.

Anaemia of chronic disease is an incorrect option as it typically results in normocytic or microcytic anemia, not macrocytic anemia.

Iron deficiency anemia is an incorrect option as it causes microcytic anemia, and the MCV value would be lower than expected.

Understanding Macrocytic Anaemia

Macrocytic anaemia is a type of anaemia that can be classified into two categories: megaloblastic and normoblastic. Megaloblastic anaemia is caused by a deficiency in vitamin B12 or folate, which leads to the production of abnormally large red blood cells in the bone marrow. This type of anaemia can also be caused by certain medications, alcohol, liver disease, hypothyroidism, pregnancy, and myelodysplasia.

On the other hand, normoblastic anaemia is caused by an increase in the number of immature red blood cells, known as reticulocytes, in the bone marrow. This can occur as a result of certain medications, such as methotrexate, or in response to other underlying medical conditions.

It is important to identify the underlying cause of macrocytic anaemia in order to provide appropriate treatment. This may involve addressing any nutritional deficiencies, managing underlying medical conditions, or adjusting medications. With proper management, most cases of macrocytic anaemia can be successfully treated.

Dilutional anemia can occur as a result of saline administration, which does not improve oxygen transport or coagulopathy.

When the blood group of a patient is unknown, O rhesus negative blood may be administered as it is considered the universal donor. However, to conserve O negative blood stocks, transfusion guidelines now recommend giving male patients O positive blood in such situations, as Rhesus status is only relevant in pregnancy.

It is crucial to ensure that the correct blood product is prescribed and administered to the right patient, as transfusion reactions can be severe and fatal.

Blood Products and Cell Saver Devices

Blood products are essential in various medical procedures, especially in cases where patients require transfusions due to anaemia or bleeding. Packed red cells, platelet-rich plasma, platelet concentrate, fresh frozen plasma, and cryoprecipitate are some of the commonly used whole blood fractions. Fresh frozen plasma is usually administered to patients with clotting deficiencies, while cryoprecipitate is a rich source of Factor VIII and fibrinogen. Cross-matching is necessary for all blood products, and cell saver devices are used to collect and re-infuse a patient’s own blood lost during surgery.

Cell saver devices come in two types, those that wash the blood cells before re-infusion and those that do not. The former is more expensive and complicated to operate but reduces the risk of re-infusing contaminated blood. The latter avoids the use of donor blood and may be acceptable to Jehovah’s witnesses. However, it is contraindicated in malignant diseases due to the risk of facilitating disease dissemination.

In some surgical patients, the use of warfarin can pose specific problems and may require the use of specialised blood products. Warfarin reversal can be achieved through the administration of vitamin K, fresh frozen plasma, or human prothrombin complex. Fresh frozen plasma is used less commonly now as a first-line warfarin reversal, and human prothrombin complex is preferred due to its rapid action. However, it should be given with vitamin K as factor 6 has a short half-life.

Prognostic Factors in Acute Lymphoblastic Leukemia

Younger patients with acute lymphoblastic leukemia (ALL) have a better prognosis than older patients. In fact, the cure rate in children is around 90%, while it is less than 40% in adults. Additionally, male patients tend to fare worse than females, and they require a longer maintenance dose of chemotherapy (3 years versus 2 years). Interestingly, the Philadelphia chromosome, which is an effective treatment target in chronic myeloid leukemia, is actually a poor prognostic marker in ALL. Finally, higher white cell counts are associated with adverse outcomes, particularly if the count exceeds 100 ×106/ml.

Overall, these prognostic factors can help clinicians predict the likelihood of a successful outcome in patients with ALL. By taking these factors into account, healthcare providers can tailor treatment plans to each patient’s individual needs and improve their chances of a positive outcome.

The origin of eosinophils is from common myeloid progenitor cells. A patient with neutrophilia and low haemoglobin is likely to have chronic myeloid leukaemia (CML). CML is characterized by increased levels of all cells derived from the myeloid lineage, including basophils, monocytes, and eosinophils. The bone marrow biopsy is diagnostic for CML and typically shows the t(9;22) chromosomal translocation, also known as the Philadelphia chromosome. Imatinib, an inhibitor of the BCR-ABL fusion protein created with this translocation, is a common treatment for CML. Cells derived from common lymphoid progenitor cells are not affected in CML.

Haematopoiesis: The Generation of Immune Cells

Haematopoiesis is the process by which immune cells are produced from haematopoietic stem cells in the bone marrow. These stem cells give rise to two main types of progenitor cells: myeloid and lymphoid progenitor cells. All immune cells are derived from these progenitor cells.

The myeloid progenitor cells generate cells such as macrophages/monocytes, dendritic cells, neutrophils, eosinophils, basophils, and mast cells. On the other hand, lymphoid progenitor cells give rise to T cells, NK cells, B cells, and dendritic cells.

This process is essential for the proper functioning of the immune system. Without haematopoiesis, the body would not be able to produce the necessary immune cells to fight off infections and diseases. Understanding haematopoiesis is crucial in developing treatments for diseases that affect the immune system.

Salmonella and Staphylococcus aureus as Causes of Osteomyelitis

Salmonella species are responsible for more than half of osteomyelitis cases in patients with sickle cell disease. The higher incidence of salmonella infections is due to various factors. The gut wall’s micro-infarcts allow the bacteria to enter the bloodstream, causing infection. Additionally, impaired splenic function leads to a weakened immune response against the pathogen.

On the other hand, Staphylococcus aureus is the most common organism that causes osteomyelitis in the general population. Although other organisms can also cause osteomyelitis, they are less frequently implicated.

The thoracoacromial artery originates from the axillary artery’s second part. It is a broad, brief trunk that penetrates the clavipectoral fascia and terminates by dividing into four branches, located deep to pectoralis major.

The Thoracoacromial Artery and its Branches

The thoracoacromial artery is a short trunk that originates from the axillary artery and is usually covered by the upper edge of the Pectoralis minor. It projects forward to the upper border of the Pectoralis minor and pierces the coracoclavicular fascia, dividing into four branches: pectoral, acromial, clavicular, and deltoid.

The pectoral branch descends between the two Pectoral muscles and supplies them and the breast, anastomosing with the intercostal branches of the internal thoracic artery and the lateral thoracic artery. The acromial branch runs laterally over the coracoid process and under the Deltoid, giving branches to it before piercing the muscle and ending on the acromion in an arterial network formed by branches from the suprascapular, thoracoacromial, and posterior humeral circumflex arteries. The clavicular branch runs upwards and medially to the sternoclavicular joint, supplying this articulation and the Subclavius. The deltoid branch arises with the acromial branch, crosses over the Pectoralis minor, and passes in the same groove as the cephalic vein, giving branches to both the Pectoralis major and Deltoid muscles.

Hyperviscosity syndrome is a condition that can occur in paraproteinemia, where there is an overproduction of IgM. This is because IgM is a pentamer, which means it is larger in size and can cause increased viscosity.

An elderly man is displaying stroke-like symptoms, but they are not in contiguous anatomical locations. This makes it unlikely that the cause is embolism or thrombosis, and suggests a global cause of ischemia. The presence of fleeting blindness (amaurosis fugax), increased viscosity, and monoclonal spike on serum electrophoresis all point towards a plasma cell dyscrasia, specifically hyperviscosity syndrome. Additional fundoscopic findings further support this suspicion.

Hyperviscosity can be caused by various conditions, but multiple myeloma is the most common. Other differentials include Waldenstrom’s macroglobulinemia and polycythemia rubra vera. The presence of generalized lymphadenopathy and splenomegaly make Waldenstrom’s macroglobulinemia more likely than the others.

In Waldenstrom’s macroglobulinemia, there is an overproduction of IgM, which is different from the other immunoglobulins as it is a pentamer. This makes it the largest immunoglobulin and more likely to cause hyperviscosity when in excess quantities. This is why Waldenstrom’s tends to present with hyperviscosity syndrome, while multiple myeloma rarely does.

Understanding Waldenstrom’s Macroglobulinaemia

Waldenstrom’s macroglobulinaemia is a rare condition that primarily affects older men. It is a type of lymphoplasmacytoid malignancy that is characterized by the production of a monoclonal IgM paraprotein. This condition can cause a range of symptoms, including systemic upset, hyperviscosity syndrome, hepatosplenomegaly, lymphadenopathy, and cryoglobulinemia.

One of the most significant features of Waldenstrom’s macroglobulinaemia is the hyperviscosity syndrome, which can lead to visual disturbances and other complications. This occurs because the pentameric configuration of IgM increases serum viscosity, making it more difficult for blood to flow through the body. Other symptoms of this condition can include weight loss, lethargy, and Raynaud’s.

To diagnose Waldenstrom’s macroglobulinaemia, doctors will typically look for a monoclonal IgM paraprotein in the patient’s blood. A bone marrow biopsy can also be used to confirm the presence of lymphoplasmacytic lymphoma cells in the bone marrow.

Treatment for Waldenstrom’s macroglobulinaemia typically involves rituximab-based combination chemotherapy. This approach can help to reduce the production of the monoclonal IgM paraprotein and alleviate symptoms associated with the condition. With proper management, many patients with Waldenstrom’s macroglobulinaemia are able to live full and healthy lives.

G6PD deficiency is a genetic disorder that affects the production of glucose-6-phosphate dehydrogenase, which is necessary for the production of NADPH. NADPH is essential for maintaining glutathione, which helps prevent oxidative damage by neutralizing free radicals. Patients with G6PD deficiency have low levels of glutathione, making them more susceptible to oxidative stress and resulting in the destruction of red blood cells. This destruction leads to an enlarged spleen and jaundice, as bilirubin is released during the breakdown of hemoglobin. The patient’s Mediterranean descent and family history of the disease suggest G6PD deficiency, which was confirmed by a G6PD enzyme assay. The presence of Heinz bodies on blood film is also characteristic of the disease. The suggestion of an autosomal dominant defect of red cells is incorrect, as this is the pathophysiology for hereditary spherocytosis, which has different clinical features and would be seen on blood film.

Understanding G6PD Deficiency

G6PD deficiency is a common red blood cell enzyme defect that is inherited in an X-linked recessive fashion and is more prevalent in people from the Mediterranean and Africa. The deficiency can be triggered by many drugs, infections, and broad (fava) beans, leading to a crisis. G6PD is the first step in the pentose phosphate pathway, which converts glucose-6-phosphate to 6-phosphogluconolactone and results in the production of nicotinamide adenine dinucleotide phosphate (NADPH). NADPH is essential for converting oxidized glutathione back to its reduced form, which protects red blood cells from oxidative damage by oxidants such as superoxide anion (O2-) and hydrogen peroxide. Reduced G6PD activity leads to decreased reduced glutathione and increased red cell susceptibility to oxidative stress, resulting in neonatal jaundice, intravascular hemolysis, gallstones, splenomegaly, and the presence of Heinz bodies on blood films. Diagnosis is made by using a G6PD enzyme assay, and some drugs are known to cause hemolysis, while others are considered safe.

Compared to hereditary spherocytosis, G6PD deficiency is more common in males of African and Mediterranean descent and is characterized by neonatal jaundice, infection/drug-induced hemolysis, and gallstones. On the other hand, hereditary spherocytosis affects both males and females of Northern European descent and is associated with chronic symptoms, spherocytes on blood films, and the presence of erythrocyte membrane protein band 4.2 (EMA) binding.

The Batson venous plexus is responsible for the majority of bony metastases in cancers commonly associated with bone metastasis, including advanced prostate cancer. This valveless venous plexus has also been linked to bone metastasis in bladder, breast, and, to a lesser extent, lung cancer.

Bone Metastases: Common Tumours and Sites

Bone metastases occur when cancer cells from a primary tumour spread to the bones. The most common tumours that cause bone metastases are prostate, breast, and lung cancer, with prostate cancer being the most frequent. The most common sites for bone metastases are the spine, pelvis, ribs, skull, and long bones.

Aside from bone pain, other features of bone metastases may include pathological fractures, hypercalcaemia, and raised levels of alkaline phosphatase (ALP). Pathological fractures occur when the bone weakens due to the cancer cells, causing it to break. Hypercalcaemia is a condition where there is too much calcium in the blood, which can lead to symptoms such as fatigue, nausea, and confusion. ALP is an enzyme that is produced by bone cells, and its levels can be elevated in the presence of bone metastases.

A common diagnostic tool for bone metastases is an isotope bone scan, which uses technetium-99m labelled diphosphonates that accumulate in the bones. The scan can show multiple irregular foci of high-grade activity in the bones, indicating the presence of metastatic cancer. In the image provided, the bone scan shows multiple osteoblastic metastases in a patient with metastatic prostate cancer.

Cisplatin causes DNA cross-linking, leading to apoptosis in cancer cells. It is commonly used in chemotherapy for various cancers. Methotrexate inhibits dihydrofolate reductase, which is not the mechanism of cisplatin. Hydroxyurea inhibits ribonucleotide reductase and is used to treat different diseases. Docetaxel prevents microtubule depolymerization and is used for breast cancer treatment. Fluorouracil blocks thymidylate synthase during S phase, leading to cell cycle arrest and apoptosis, but it is not the mechanism of cisplatin.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and potential adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin and anthracyclines, degrade preformed DNA and stabilize DNA-topoisomerase II complex, respectively. However, they can also cause lung fibrosis and cardiomyopathy. Antimetabolites, such as methotrexate and fluorouracil, inhibit dihydrofolate reductase and thymidylate synthesis, respectively. However, they can also cause myelosuppression, mucositis, and liver or lung fibrosis. Drugs that act on microtubules, like vincristine and docetaxel, inhibit the formation of microtubules and prevent microtubule depolymerisation & disassembly, respectively. However, they can also cause peripheral neuropathy, myelosuppression, and paralytic ileus. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I, which prevents relaxation of supercoiled DNA. However, they can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin and hydroxyurea, cause cross-linking in DNA and inhibit ribonucleotide reductase, respectively. However, they can also cause ototoxicity, peripheral neuropathy, hypomagnesaemia, and myelosuppression.

Generalized lymphadenopathy may be caused by the Epstein-Barr Virus, which can also be linked to splenomegaly. This enlargement has been known to result in spontaneous rupture.

The Anatomy and Function of the Spleen

The spleen is an organ located in the left upper quadrant of the abdomen. Its size can vary depending on the amount of blood it contains, but the typical adult spleen is 12.5cm long and 7.5cm wide, with a weight of 150g. The spleen is almost entirely covered by peritoneum and is separated from the 9th, 10th, and 11th ribs by both diaphragm and pleural cavity. Its shape is influenced by the state of the colon and stomach, with gastric distension causing it to resemble an orange segment and colonic distension causing it to become more tetrahedral.

The spleen has two folds of peritoneum that connect it to the posterior abdominal wall and stomach: the lienorenal ligament and gastrosplenic ligament. The lienorenal ligament contains the splenic vessels, while the short gastric and left gastroepiploic branches of the splenic artery pass through the layers of the gastrosplenic ligament. The spleen is in contact with the phrenicocolic ligament laterally.

The spleen has two main functions: filtration and immunity. It filters abnormal blood cells and foreign bodies such as bacteria, and produces properdin and tuftsin, which help target fungi and bacteria for phagocytosis. The spleen also stores 40% of platelets, utilizes iron, and stores monocytes. Disorders of the spleen include massive splenomegaly, myelofibrosis, chronic myeloid leukemia, visceral leishmaniasis, malaria, Gaucher’s syndrome, portal hypertension, lymphoproliferative disease, haemolytic anaemia, infection, infective endocarditis, sickle-cell, thalassaemia, and rheumatoid arthritis.

ESR and its association with diseases

Erythrocyte sedimentation rate (ESR) is a laboratory test that measures the rate at which red blood cells settle in a tube over a period of time. Elevated ESR levels are often associated with inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and polymyalgia rheumatica. In these conditions, the body’s immune system is activated, leading to inflammation and tissue damage. Malignancies such as myeloma can also cause an increase in ESR levels, particularly in females and with increasing age.

On the other hand, low ESR levels are seen in conditions such as polycythaemia, where there is an excess of red blood cells in the body. It is important to note that ESR is not a specific diagnostic test and must be interpreted in conjunction with other clinical findings. Multiple myeloma, a type of plasma cell neoplasm, is the most common haematological malignancy and can lead to a range of symptoms such as hypercalcaemia, renal failure, anaemia, and bone pain. While it is not curable, advances in treatment have significantly improved the median survival of patients. the association between ESR and various diseases can aid in the diagnosis and management of these conditions.

The upper limb drains into the axillary lymph nodes, which can become painful and may lead to lymphadenitis in cases of secondary bacterial infection. The correct dermatome for sensory innervation of the lateral half of the forearm is C6, while C2 provides sensory innervation to the posterior half of the head, L2 to the anterior thighs, and T8 to a horizontal band around the torso below the umbilicus (T10), all of which are drained by different lymph nodes.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

The thymus is where T-cells undergo maturation, while they are produced in the bone marrow. Once mature, they can be found in the spleen and lymph nodes where they interact with antigen presenting cells. To investigate the impact of HIV on T-cell maturation, a thymus sample is necessary.

Understanding the Lymphatic System

The lymphatic system is composed of primary and secondary lymphatic organs, as well as lymph vessels. The primary lymphatic organs are the thymus and red bone marrow, which are responsible for the formation and maturation of lymphocytes. These organs contain pluripotent cells that give rise to immunocompetent B cells and pre-T cells. To become mature T cells, pre-T cells must migrate to the thymus.

On the other hand, secondary lymphatic organs include lymph nodes, the spleen, tonsils, mucosa-associated lymphoid tissue (MALT), and Peyer’s patches. These organs filter lymphocytes and activate them to mount an immune response. Understanding the lymphatic system is crucial in comprehending how the body’s immune system works. By knowing the different organs and their functions, we can appreciate how the body fights off infections and diseases.

Understanding Acute Lymphoblastic Leukaemia

Acute lymphoblastic leukaemia (ALL) is a type of cancer that commonly affects children, accounting for 80% of childhood leukaemias. It is most prevalent in children aged 2-5 years, with boys being slightly more affected than girls. Symptoms of ALL can be divided into those caused by bone marrow failure, such as anaemia, neutropaenia, and thrombocytopenia, and other features like bone pain, splenomegaly, hepatomegaly, fever, and testicular swelling.

There are three types of ALL: common ALL, T-cell ALL, and B-cell ALL. Common ALL is the most common type, accounting for 75% of cases, and is characterized by the presence of CD10 and pre-B phenotype. T-cell ALL accounts for 20% of cases, while B-cell ALL accounts for only 5%.

Certain factors can affect the prognosis of ALL, including age, white blood cell count at diagnosis, T or B cell surface markers, race, and sex. Children under 2 years or over 10 years of age, those with a WBC count over 20 * 109/l at diagnosis, and those with T or B cell surface markers, non-Caucasian, and male sex have a poorer prognosis.

Understanding the different types and prognostic factors of ALL can help in the early detection and management of this cancer. It is important to seek medical attention if any of the symptoms mentioned above are present.

Von Willebrand’s disease is a genetic cause of coagulation disorders that can result in prolonged bleeding time and nosebleeds. On the other hand, disseminated intravascular coagulation is an acquired condition that does not typically cause increased bleeding time but may occur in patients with sepsis. Acquired hemophilia is also an acquired condition that is not associated with a family history of bleeding disorders. Vitamin K deficiency can lead to increased bleeding time, bruising, and nosebleeds. Reduced liver function can also result in decreased production of clotting factors and an increased risk of bleeding, but this is unlikely to be the cause of the patient’s symptoms based on their medical history.

Understanding Coagulation Disorders

Coagulation disorders refer to conditions that affect the body’s ability to form blood clots. These disorders can be hereditary or acquired. Hereditary coagulation disorders include haemophilia A, haemophilia B, and von Willebrand’s disease. These conditions are caused by genetic mutations that affect the production or function of certain clotting factors in the blood.

On the other hand, acquired coagulation disorders are caused by external factors that affect the body’s ability to form blood clots. These factors include vitamin K deficiency, liver disease, and disseminated intravascular coagulation (DIC). DIC can also cause thrombocytopenia, which is a condition characterized by low platelet counts in the blood. Another acquired coagulation disorder is acquired haemophilia, which is a rare autoimmune disorder that causes the body to produce antibodies that attack clotting factors in the blood.

It is important to understand coagulation disorders as they can lead to serious health complications such as excessive bleeding or blood clots. Treatment for coagulation disorders varies depending on the underlying cause and severity of the condition. It may include medication, blood transfusions, or surgery. Regular monitoring and management of these conditions can help prevent complications and improve quality of life.

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.

Hodgkin’s disease is characterized by the presence of Reed-Sternberg cells in histological examination.

Causes of Generalised Lymphadenopathy

Generalised lymphadenopathy refers to the enlargement of multiple lymph nodes throughout the body. There are various causes of this condition, including infectious, neoplastic, and autoimmune conditions. Infectious causes include infectious mononucleosis, HIV, eczema with secondary infection, rubella, toxoplasmosis, CMV, tuberculosis, and roseola infantum. Neoplastic causes include leukaemia and lymphoma. Autoimmune conditions such as SLE and rheumatoid arthritis, graft versus host disease, and sarcoidosis can also cause generalised lymphadenopathy. Additionally, certain drugs like phenytoin and to a lesser extent allopurinol and isoniazid can also lead to this condition. It is important to identify the underlying cause of generalised lymphadenopathy to determine the appropriate treatment.

If Howell-Jolly bodies are present in the peripheral smear of a sickle cell anemia patient, it indicates that they have undergone autosplenectomy. Sickle cell disease can lead to various complications, including vaso-occlusive crisis, parvovirus B19 infections, splenic sequestration, and eventually, autosplenectomy. However, based on the absence of symptoms and other factors, vaso-occlusive crisis, parvovirus B19 infection, and splenic sequestration are unlikely causes in this case.

Pathological Red Cell Forms in Blood Films

Blood films are used to examine the morphology of red blood cells and identify any abnormalities. Pathological red cell forms are associated with various conditions and can provide important diagnostic information. Some of the common pathological red cell forms include target cells, tear-drop poikilocytes, spherocytes, basophilic stippling, Howell-Jolly bodies, Heinz bodies, schistocytes, pencil poikilocytes, burr cells (echinocytes), and acanthocytes.

Target cells are seen in conditions such as sickle-cell/thalassaemia, iron-deficiency anaemia, hyposplenism, and liver disease. Tear-drop poikilocytes are associated with myelofibrosis, while spherocytes are seen in hereditary spherocytosis and autoimmune hemolytic anaemia. Basophilic stippling is a characteristic feature of lead poisoning, thalassaemia, sideroblastic anaemia, and myelodysplasia. Howell-Jolly bodies are seen in hyposplenism, while Heinz bodies are associated with G6PD deficiency and alpha-thalassaemia. Schistocytes or ‘helmet cells’ are seen in conditions such as intravascular haemolysis, mechanical heart valve, and disseminated intravascular coagulation. Pencil poikilocytes are seen in iron deficiency anaemia, while burr cells (echinocytes) are associated with uraemia and pyruvate kinase deficiency. Acanthocytes are seen in abetalipoproteinemia.

In addition to these red cell forms, hypersegmented neutrophils are seen in megaloblastic anaemia. Identifying these pathological red cell forms in blood films can aid in the diagnosis and management of various conditions.

The most probable reason for the patient’s fatigue and abnormal blood results is the side effect of phenytoin. Phenytoin is an antifolate medication that can lead to folate deficiency, resulting in macrocytic anaemia, which is evident in the patient’s blood test. Fatigue is a common symptom of anaemia, which the patient has reported.

Although lack of sleep may contribute to the patient’s tiredness, it alone cannot cause macrocytic anaemia.

Hypothyroidism can cause macrocytic anaemia and lethargy, but it is less likely to be the cause of the patient’s symptoms. The patient has no history of thyroid disorders, and his slim build and anxiety are more typical of hyperthyroidism.

Loratadine is a second-generation antihistamine that does not usually cause drowsiness.

Understanding Macrocytic Anaemia

Macrocytic anaemia is a type of anaemia that can be classified into two categories: megaloblastic and normoblastic. Megaloblastic anaemia is caused by a deficiency in vitamin B12 or folate, which leads to the production of abnormally large red blood cells in the bone marrow. This type of anaemia can also be caused by certain medications, alcohol, liver disease, hypothyroidism, pregnancy, and myelodysplasia.

On the other hand, normoblastic anaemia is caused by an increase in the number of immature red blood cells, known as reticulocytes, in the bone marrow. This can occur as a result of certain medications, such as methotrexate, or in response to other underlying medical conditions.

It is important to identify the underlying cause of macrocytic anaemia in order to provide appropriate treatment. This may involve addressing any nutritional deficiencies, managing underlying medical conditions, or adjusting medications. With proper management, most cases of macrocytic anaemia can be successfully treated.

The presence of factor V Leiden mutation leads to resistance to activated protein C.

The most probable cause of the patient’s recurrent DVTs and family history of thrombo-embolic events is factor V Leiden, which is the most common inherited thrombophilia. This mutation results in activated protein C resistance, as activated factor V is not inactivated as efficiently by protein C.

Antiphospholipid syndrome is an acquired thrombophilia that can cause both arterial and venous thromboses, and may present with thrombocytopenia. However, the patient’s positive family history and normal full blood count make this diagnosis less likely than factor V Leiden.

Protein C deficiency, protein S deficiency, and antithrombin III deficiency are all inherited thrombophilias, but they are less prevalent in the population compared to factor V Leiden. Therefore, they are less likely to be the underlying cause of the patient’s symptoms.

Understanding Factor V Leiden

Factor V Leiden is a common inherited thrombophilia, affecting around 5% of the UK population. It is caused by a mutation in the Factor V Leiden protein, resulting in activated factor V being inactivated 10 times more slowly by activated protein C than normal. This leads to activated protein C resistance, which increases the risk of venous thrombosis. Heterozygotes have a 4-5 fold risk of venous thrombosis, while homozygotes have a 10 fold risk, although the prevalence of homozygotes is much lower at 0.05%.

Despite its prevalence, screening for Factor V Leiden is not recommended, even after a venous thromboembolism. This is because a previous thromboembolism itself is a risk factor for further events, and specific management should be based on this rather than the particular thrombophilia identified.

Other inherited thrombophilias include Prothrombin gene mutation, Protein C deficiency, Protein S deficiency, and Antithrombin III deficiency. The table below shows the prevalence and relative risk of venous thromboembolism for each of these conditions.

Overall, understanding Factor V Leiden and other inherited thrombophilias can help healthcare professionals identify individuals at higher risk of venous thrombosis and provide appropriate management to prevent future events.

Condition | Prevalence | Relative risk of VTE
— | — | —
Factor V Leiden (heterozygous) | 5% | 4
Factor V Leiden (homozygous) | 0.05% | 10
Prothrombin gene mutation (heterozygous) | 1.5% | 3
Protein C deficiency | 0.3% | 10
Protein S deficiency | 0.1% | 5-10
Antithrombin III deficiency | 0.02% | 10-20

Vitamin deficiency may occur after an ileocaecal resection.

Vitamin B12 is essential for the development of red blood cells and the maintenance of the nervous system. It is absorbed through the binding of intrinsic factor, which is secreted by parietal cells in the stomach, and actively absorbed in the terminal ileum. A deficiency in vitamin B12 can be caused by pernicious anaemia, post gastrectomy, a vegan or poor diet, disorders or surgery of the terminal ileum, Crohn’s disease, or metformin use.

Symptoms of vitamin B12 deficiency include macrocytic anaemia, a sore tongue and mouth, neurological symptoms, and neuropsychiatric symptoms such as mood disturbances. The dorsal column is usually affected first, leading to joint position and vibration issues before distal paraesthesia.

Management of vitamin B12 deficiency involves administering 1 mg of IM hydroxocobalamin three times a week for two weeks, followed by once every three months if there is no neurological involvement. If a patient is also deficient in folic acid, it is important to treat the B12 deficiency first to avoid subacute combined degeneration of the cord.

Hyper IgM syndrome is caused by mutations in the CD40 gene, which affects the ability of B cells to produce immunoglobulin A, G, and E. While the production of IgM is still possible, the process of switching to other antibodies is impaired due to a lack of activated T-cells. This results in increased susceptibility to infections during early childhood. Treatment options include regular immunoglobulin, antibiotics, and granulocyte-colony stimulating factor (GCS-F).

Overview of Primary Immunodeficiency Disorders

Primary immunodeficiency disorders are conditions that affect the immune system’s ability to fight off infections and diseases. These disorders can be classified based on which component of the immune system is affected. Neutrophil disorders, for example, are caused by a lack of NADPH oxidase, which reduces the ability of phagocytes to produce reactive oxygen species. This leads to recurrent pneumonias and abscesses, particularly due to catalase-positive bacteria and fungi. B-cell disorders, on the other hand, are caused by defects in B cell development, resulting in low antibody levels and recurrent infections. T-cell disorders are caused by defects in T cell development, leading to recurrent viral and fungal diseases. Finally, combined B- and T-cell disorders are caused by defects in both B and T cell development, resulting in recurrent infections and an increased risk of malignancy. Understanding the underlying defects and symptoms of these disorders is crucial for proper diagnosis and treatment.

Unless proven otherwise, the presence of neurological symptoms along with abdominal pain may indicate either acute intermittent porphyria or lead poisoning.

Understanding Acute Intermittent Porphyria

Acute intermittent porphyria (AIP) is a rare genetic disorder that affects the biosynthesis of haem due to a defect in the porphobilinogen deaminase enzyme. This results in the accumulation of delta aminolaevulinic acid and porphobilinogen, leading to a range of symptoms. AIP typically presents in individuals aged 20-40 years, with females being more commonly affected.

The condition is characterized by a combination of abdominal, neurological, and psychiatric symptoms. Abdominal symptoms include pain and vomiting, while neurological symptoms may manifest as motor neuropathy. Psychiatric symptoms may include depression. Hypertension and tachycardia are also common.

Diagnosis of AIP involves a range of tests, including urine analysis, assay of red cells for porphobilinogen deaminase, and measurement of serum levels of delta aminolaevulinic acid and porphobilinogen. A classic sign of AIP is the deep red color of urine on standing.

Management of AIP involves avoiding triggers and treating acute attacks with IV haematin/haem arginate. In cases where these treatments are not immediately available, IV glucose may be used. With proper management, individuals with AIP can lead healthy and fulfilling lives.